Dr. Reddy’s Laboratories’ (DRL ... US sales posted growth of 15.6% YoY to USD 445mn, likely driven by gRevlimid (pegged at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback